Recently diagnosed with HIV? Click here

Pre-exposure prophylaxis (PrEP)

Pre-Exposure Prophylaxis (PrEP) is a technology intended to prevent HIV transmission by giving antiretroviralA medication or other substance which is active against retroviruses such as HIV. drugs to HIV negative people at risk of HIV infection. There is some evidence to suggest PrEP may be effective in some circumstances. It is not currently available in Australia.

US PrEP guidelines released

Positive Living article • Adrian Ogier • 30 August 2012
HIV prevention

As a follow-up to the preliminary guidelines regarding pre-exposure prophylaxis (PrEP) for men who have sex with men, the US Centers for Disease Control and Prevention have also issued interim recommendations for heterosexually active adults. read more »

19th International AIDS Conference opens in Washington DC

Media release • 23 July 2012

On the eve of the world’s largest gathering of AIDS researchers, activists and policy makers, NAPWHA is calling on the Australian Government to show greater leadership in international efforts to finally end the global AIDS epidemic. read more »

Time for Australia to get its act together

Media release • 17 July 2012

Landmark US approval of the drug (Truvada) TDF/FTC for use in preventing HIV infections in sexually active HIV negative adults read more »

Spotlight on Seattle

Positive Living article • Adrian Ogier • 7 June 2012

The 19th Conference on Retroviruses and Opportunistic Infections (Croi) was held in Seattle in march. Here are some important highlights. read more »

Report from Rome - 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention

Story • www.i-base.info • 28 July 2011

The 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention was held in Rome last week from 17-20 July. This meeting is held every two years and alternates with the much larger World AIDS Conferences also organised by the International AIDS Society (IAS). read more »

Microbicides, PrEP and treatment as prevention

Positive Living article • Paul Kidd • 2 September 2010
HIV prevention

Significant advances in HIV prevention were unveiled at the XVIII International AIDS Conference in Vienna, with research advancing on several fronts towards new prevention technologies. Paul Kidd reports. read more »

Rocky Mountain CROI

Positive Living article • Paul Kidd • 27 April 2006

The 13th annual Conference on Retroviruses and Opportunistic Infections (CROI) took place in Denver, Colorado, from February 5 to 8. The major breaking news from this conference was the premature cancellation of the SMART study, but as usual, this important conference produced a great deal more than a single story. read more »

PREParing the facts

Story • Kirsty Machon • 11 October 2005
The global HIV epidemic

Kirsty Machon questions the misinformation, controversy and conspiracy theories which put an end to the proposed PREP trials among sex workers in Cambodia and Cameroon. read more »

Emerging information about the pathogenesis of HIV: implications for urgency of PEP and PREP Research

Story • Kirsty Machon • 11 October 2005
Defeating HIV

A summary of current research into CD4 cell loss in early infection and its implications for HIV prevention, by NAPWHA policy analyst Kirsty Machon. read more »

Cambodian PREP trial halted

Positive Living article • Paul Kidd • 15 August 2004
The global HIV epidemic

A controversial Cambodian trial of tenofovir for pre-exposure prophylaxis (PREP) is unlikely to proceed after sex workers and the Cambodian government claimed the trial did not include adequate safeguards for the health and human rights of the participants. read more »

12next ›last »
Syndicate content
Text size: font smallerfont normalfont larger

Stay in touch

NAPWHA's email newsletters provide regular info about issues affecting people with HIV and the response to HIV in Australia. Click here to subscribe.

Subscribe to Positive Living

Our free quarterly newsmagazine, Positive Living provides authoritative, independent information about living with HIV and HIV treatments. Click here to subscribe.

RSS feeds

Our website has RSS feeds covering all topic areas — just go to the topic area you're interested in and click the RSS feed icon.

Twitter users can stay up-to-date with NAPWHA's work and be alerted to new content on the website by following @napwa.

Join us on Facebook NAPWHA Facebook.

Find out more at LinkedIn

Find out more about NAPWHA at LinkedInNAPWHA at LinkedIn.

HIV Clinical Trials update

Recently updated entries from the NAPWHA Clinical Trials database.

more